SCHEMBL6851650

SCHEMBL6851650

C=C(C)C(=O)OCCC(COP(=O)([O-])O)[N+](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
THRB P10828 1/20 0.36
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176509 0.89 TSHR (0.40) TSHRTHRBALDH1A1
SCHEMBL541535 0.87 THRB (0.38) TSHRTHRBALDH1A1
SCHEMBL541550 0.85 TSHR (0.38) TSHRTHRB
SCHEMBL541928 0.83 TSHR (0.43) TSHRTHRB
SCHEMBL2038860 0.82 THRB (0.39) TSHRTHRBALDH1A1
SCHEMBL2944692 0.82 THRB (0.44) TSHRTHRBALDH1A1
SCHEMBL541439 0.81 TSHR (0.42) TSHRTHRBALDH1A1
SCHEMBL28018330 0.81 TSHR (0.36) TSHRTHRBALDH1A1
SCHEMBL27781350 0.80 THRB (0.40) TSHRTHRBALDH1A1
SCHEMBL541226 0.80 TSHR (0.44) TSHRTHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263512-A1 POLYMER COMPOSITIONS CONTAINING GRAFTED POLYMERIC NETWORKS AND PROCESSES FOR THEIR PREPARATION AND USE JOHNSON & JOHNSON VISION CARE (US) 2025-08-21 US claimed
WO-2023021885-A1 ELECTROLYTIC SOLUTION FOR CAPACITOR AND CAPACITOR カーリットホールディングス株式会社 2023-02-23 WO claimed
WO-2023013368-A1 METHOD FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR カーリットホールディングス株式会社 2023-02-09 WO claimed
US-10927206-B2 Copolymer and application therefor NOF CORPORATION (JP) 2021-02-23 US claimed
US-10323132-B2 Polymer and crosslinked body thereof NOF CORPORATION (JP) 2019-06-18 US claimed
US-20190153137-A1 COPOLYMER AND APPLICATION THEREFOR NOF CORPORATION (JP) 2019-05-23 US claimed
EP-2725042-B1 POLYMER AND METHOD FOR PRODUCING SAME NOF CORP (JP) 2018-08-29 EP claimed
US-20180051140-A1 POLYMER AND CROSSLINKED BODY THEREOF THE UNIVERSITY OF TOKYO (JP) 2018-02-22 US claimed
EP-3266803-A2 POLYMER AND CROSSLINKED BODY THEREOF The University of Tokyo (JP) 2018-01-10 EP claimed
US-20160281077-A1 MEDIUM AND METHOD FOR CULTURING EUGLENA AND METHOD FOR REDUCING PHOTOINHIBITION IN EUGLENA EUGLENA CO., LTD. (JP) 2016-09-29 US claimed
US-9127099-B2 Polymer and method for producing same NOF CORPORATION (JP) 2015-09-08 US claimed
US-20140142240-A1 POLYMER AND METHOD FOR PRODUCING SAME NOF CORPORATION (JP) 2014-05-22 US claimed
EP-2725042-A1 POLYMER AND METHOD FOR PRODUCING SAME NOF Corporation (JP) 2014-04-30 EP claimed
US-6828028-B1 Having surface treated with copolymer of such as ring opened glycidyl methacrylate and 2-(methacryloyloxy)ethyl-2-(tri-methylammonio)ethylphosphate; lubricity, blood compatible, safe, stable, durable NOF CORPORATION (JP) 2004-12-07 US claimed
US-20260071075-A1 PURIFICATION METHOD OF NANOPARTICLE, NANOPARTICLE COMPOSITION, AND MANUFACTURING METHOD OF NANOPARTICLE COMPOSITION CANON KK (JP) 2026-03-12 US disclosed
US-20250263512-A1 POLYMER COMPOSITIONS CONTAINING GRAFTED POLYMERIC NETWORKS AND PROCESSES FOR THEIR PREPARATION AND USE JOHNSON & JOHNSON VISION CARE (US) 2025-08-21 US disclosed
US-12384934-B2 Surface treatment agent for soft contact lens NOF CORPORATION (JP) 2025-08-12 US disclosed
EP-0767212-B1 PROCESS FOR PRODUCING AN AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER AND AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER NOF CORP (JP) 2001-07-18 EP disclosed
US-6204324-B1 AN ETHYLENICALLY UNSATURATED POLYMERIZABLE MONOMER HAVING THE PHOSPHORYLCHOLINE GROUP IS POLYMERIZED IN THE PRESENCE OF A NON-METAL POLYMERIZATION INITIATOR SOLUTION CONTAINING PEROXY OR AZO COMPOUNDS NOF CORPORATION (JP) 2001-03-20 US disclosed
EP-0767212-A1 PROCESS FOR PRODUCING AN AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER AND AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER Japan Science and Technology Corporation (JP) 1997-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071075-A1 PURIFICATION METHOD OF NANOPARTICLE, NANOPARTICLE COMPOSITION, AND MANUFACTURING METHOD OF NANOPARTICLE COMPOSITION CSPP1, PLTP, CD47 TSHR 1497/4885THRB 4077/4885ALDH1A1 2680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.